Skip to main content

Table 2 Quality assessment of included studies

From: Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021

Study

Random sequence generation (selection bias)

Allocation concealment (selection bias)

Blinding of participants and personnel (performance bias)

Blinding outcome assessment (detection bias)

Incomplete outcome data (attrition bias)

Selective reporting (reporting bias)

Other risk of bias

(power & baseline imbalance)

Direct meta-analysis and network meta-analysis—RCTs of LDCT screening

 DANTE [39]

Low

Unclear

Low

Low

Low

Low

Low & low

 DLCST [41]

Low

Unclear

Low

Low

Low

Low

Low & low

 ITALUNG [43]

Low

Low

Low

Low

Low

Low

Unclear and low

 LSS [44]

Low

Low

Low

Low

Low

Unclear

High and low

 LUSI [45]

Low

Unclear

Low

Low

Low

Low

Unclear and low

 MILD [46]

Unclear

Unclear

Low

Low

Low

Low

High and high

 NELSON [47]

Unclear

Unclear

Low

Low

Low

Low

Low and low

 NLST [49]

Low

Unclear

Low

Low

Low

Low

Low and low

 UKLS [52]

Low

Low

Low

Low

Low

Low

Unclear and low

Network meta-analysis (main) – RCTs of CXR screening

 Czech [56]

Low

Unclear

Low

Unclear

Unclear

Low

Unclear and low

 MAYO [59, 60]

Unclear

Unclear

Low

Low

Low

Low

Low and low

Network meta-analysis (sensitivity)—RCTs of CXR screening (post hoc defined high-risk sub-group of larger RCT)

 PLCO [62]

Low

Unclear

Low

Low

Low

Low

High and low

  1. Abbreviations: CXR chest X-ray, LDCT low-dose computed tomography, RCT randomised controlled trial, N not reported, yrs years
  2. Descriptors for each aspect of study quality indicate risk of bias